The Lancet Microbe : Impact Factor & More
eISSN: 2666-5247pISSN: 2666-5247
Open AccessShare this on:
Key Metrics
CiteScore 
18.4
Scite Index
0.89 5-Year SI
SNIP
6.5
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on The Lancet Microbe
The Lancet Microbe Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 6300 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2020 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in The Lancet Microbe ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in The Lancet Microbe
Spatially resolved architecture of the human gut microbiome and its health implications.
- 10 Feb 2027
- The Lancet. Microbe
Temporal variations of the gut microbiome in human health.
- 10 Feb 2027
- The Lancet. Microbe
Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.
- 31 Dec 2026
- The Lancet. Microbe
Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.
- 18 Dec 2026
- The Lancet. Microbe
High-temperature tolerance of bat and pangolin sarbecoviruses versus SARS-CoV-2.
- 1 Jul 2026
- The Lancet. Microbe
Convergence of hypervirulence and multidrug resistance driven by plasmid hybridisation and insertion sequence-mediated chromosomal integration in Klebsiella pneumoniae.
- 1 Jul 2026
- The Lancet. Microbe
Spatially resolved architecture of the human gut microbiome and its health implications.
- 10 Feb 2027
- The Lancet. Microbe
Temporal variations of the gut microbiome in human health.
- 10 Feb 2027
- The Lancet. Microbe
Efficacy of chloroquine plus low-dose primaquine and pyronaridine-artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.
- 31 Dec 2026
- The Lancet. Microbe
Evaluation of the effectiveness of artemether-lumefantrine and artesunate-pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial.
- 18 Dec 2026
- The Lancet. Microbe
High-temperature tolerance of bat and pangolin sarbecoviruses versus SARS-CoV-2.
- 1 Jul 2026
- The Lancet. Microbe
Convergence of hypervirulence and multidrug resistance driven by plasmid hybridisation and insertion sequence-mediated chromosomal integration in Klebsiella pneumoniae.
- 1 Jul 2026
- The Lancet. Microbe
FAQs on The Lancet Microbe
How long has The Lancet Microbe been actively publishing? 
What is the publishing frequency of The Lancet Microbe?
How many articles did The Lancet Microbe publish last year?
What is the eISSN & pISSN for The Lancet Microbe?
What is Citescore for The Lancet Microbe?
What is SNIP score for The Lancet Microbe?
Who is the publisher of The Lancet Microbe?
